InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
1
T+90 胜率
0%
T+90 平均收益
-24.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Fountain Nathan B, 董事. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. In total, 4 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €85k. History available since 6 July 2021. The latest transaction was disclosed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Fountain Nathan B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
6,400 股Common StockSEC:0001628280-26-042280:0
35,500 股0Common StockSEC:0001628280-26-041281:0
12,800 股0Common StockSEC:0001576885-25-000080:0
6,250 股@ US$16.00100.0% 占其流量Common StockSEC:0001209191-21-046026:0
标准退出：2021年10月4日 (T+90)
4 条申报中的 4 条
About Fountain Nathan B
Nathan B. Fountain is a Board Member at Acumen Pharmaceuticals, Inc. He plays a key role in the governance of the company, contributing to strategic decision-making and the overall direction of the organization. His experience is valuable for Acumen.
